228 related articles for article (PubMed ID: 9307266)
1. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices.
Boissier S; Magnetto S; Frappart L; Cuzin B; Ebetino FH; Delmas PD; Clezardin P
Cancer Res; 1997 Sep; 57(18):3890-4. PubMed ID: 9307266
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
Boissier S; Ferreras M; Peyruchaud O; Magnetto S; Ebetino FH; Colombel M; Delmas P; Delaissé JM; Clézardin P
Cancer Res; 2000 Jun; 60(11):2949-54. PubMed ID: 10850442
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.
van der Pluijm G; Vloedgraven H; van Beek E; van der Wee-Pals L; Löwik C; Papapoulos S
J Clin Invest; 1996 Aug; 98(3):698-705. PubMed ID: 8698861
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates for cancer patients: why, how, and when?
Body JJ; Mancini I
Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells.
Kaiser T; Teufel I; Geiger K; Vater Y; Aicher WK; Klein G; Fehm T
Breast Cancer Res Treat; 2013 Jul; 140(1):35-48. PubMed ID: 23807419
[TBL] [Abstract][Full Text] [Related]
6. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates induce breast cancer cell death in vitro.
Fromigue O; Lagneaux L; Body JJ
J Bone Miner Res; 2000 Nov; 15(11):2211-21. PubMed ID: 11092402
[TBL] [Abstract][Full Text] [Related]
8. Additive antitumor activities of taxoids in combination with the bisphosphonate ibandronate against invasion and adhesion of human breast carcinoma cells to bone.
Magnetto S; Boissier S; Delmas PD; Clezardin P
Int J Cancer; 1999 Oct; 83(2):263-9. PubMed ID: 10471537
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of bisphosphonates.
Green JR
Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.
Fournier P; Boissier S; Filleur S; Guglielmi J; Cabon F; Colombel M; Clézardin P
Cancer Res; 2002 Nov; 62(22):6538-44. PubMed ID: 12438248
[TBL] [Abstract][Full Text] [Related]
12. How do bisphosphonates inhibit bone metastasis in vivo?
Fournier PG; Stresing V; Ebetino FH; Clézardin P
Neoplasia; 2010 Jul; 12(7):571-8. PubMed ID: 20651986
[TBL] [Abstract][Full Text] [Related]
13. The bisphosphonate pamidronate is a potent inhibitor of human osteosarcoma cell growth in vitro.
Sonnemann J; Eckervogt V; Truckenbrod B; Boos J; Winkelmann W; van Valen F
Anticancer Drugs; 2001 Jun; 12(5):459-65. PubMed ID: 11395574
[TBL] [Abstract][Full Text] [Related]
14. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of bone metastasis.
Mundy GR
Cancer; 1997 Oct; 80(8 Suppl):1546-56. PubMed ID: 9362421
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis-mediated cytotoxic effects of ibandronic acid on hormone- and drug-refractory prostate cancer cells and human breast cancer cells.
Kucukzeybek Y; Gorumlu G; Cengiz E; Karabulut B; Sezgin C; Atmaca H; Sanli UA; Uzunoglu S; Uslu R
J Int Med Res; 2010; 38(5):1663-72. PubMed ID: 21309480
[TBL] [Abstract][Full Text] [Related]
17. Bone microenvironment-mediated resistance of cancer cells to bisphosphonates and impact on bone osteocytes/stem cells.
Alasmari A; Lin SC; Dibart S; Salih E
Clin Exp Metastasis; 2016 Aug; 33(6):563-88. PubMed ID: 27155840
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tumor formation by snake venom disintegrin.
Yang RS; Tang CH; Chuang WJ; Huang TH; Peng HC; Huang TF; Fu WM
Toxicon; 2005 Apr; 45(5):661-9. PubMed ID: 15777962
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonates: preclinical review.
Green JR
Oncologist; 2004; 9 Suppl 4():3-13. PubMed ID: 15459425
[TBL] [Abstract][Full Text] [Related]
20. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG
Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
